Percutaneous mechanical cardiac assist in myocardial infarction. Where are we now, where are we going?

Acute Cardiac Care

Volumn 9, Issue 4, 2007, Pages 222-230

  Sjauw, Krischan D ^a   Engström, Annemarie E ^a   Henriques, José P S ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; Cardiogenic shock; LV recovery; LVAD; Myocardial infarction

Indexed keywords

OXYGEN;

AORTA BALLOON; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; DEVICE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEMODYNAMICS; HUMAN; OXYGEN CONSUMPTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW;

ASSISTED CIRCULATION; HUMANS; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC;

EID: 36348979155     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940701534818     Document Type: Review

References (48)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-8.
2. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-54.
3. Bouki KP, Pavlakis G, Papasteriadis E. Management of cardiogenic shock due to acute coronary syndromes. Angiology. 2005;56:123-30.
4. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625-34.
5. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002.
6. Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation. 1992;85:1152-9.
7. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol. 2003;41:1087-95.
8. Nishi K, Mori F, Miyamoto M, Esato K. Myocardial protection by a left ventricular assist device during reperfusion following acute coronary occlusion. Jpn J Surg. 1989;19:563-9.
9. Matsumoto N, Miyamoto M, Mori F, Esato K. The effect of the left ventricular assist device on the myocardium during reperfusion after coronary artery occlusion. Jpn J Surg. 1990;20:300-6.
10. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL, Jr. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113-8.
11. Bregman D, Casarella WJ. Percutaneous intraaortic balloon pumping: initial clinical experience. Ann Thorac Surg. 1980;29:153-5.
12. Azevedo CF, Amado LC, Kraitchman DL, Gerber BL, Edvardsen T, Osman NF, et al. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J. 2005;26:1235-41.
13. Haston HH, McNamara JJ. The effects of intraaortic balloon counterpulsation on myocardial infarct size. Ann Thorac Surg. 1979;28:335-41.
14. Laas J, Campbell CD, Takanashi Y, Pick RL, Replogle RL. Failure of intra-aortic balloon pumping to reduce experimental myocardial infarct size in swine. J Thorac Cardiovasc Surg. 1980;80:85-93.
15. van 't Hof AW, Liem AL, de Boer MJ, Hoorntje JC, Suryapranata H, Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999;20:659-65.
16. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second primary angioplasty in myocardial infarction (PAMI-II) trial investigators. J Am Coll Cardiol. 1997;29:1459-67.
17. Conti CR. Myocardial infarction, urgent angioplasty and intra-arterial balloon counterpulsation. Eur Heart J. 1999;20:638-40.
18. Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, Cohen M, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol. 2003;41:1940-5.
19. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004;110:e82-292.
20. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933-9.
21. Mehta SM, Aufiero TX, Pae WE, Jr, Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report - 1994. J Heart Lung Transplant. 1995;14:585-93.
22. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
23. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873-84.
24. Chen JM, DeRose JJ, Slater JP, Spanier TB, Dewey TM, Catanese KA, et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol. 1999;33:1903-8.
25. Park SJ, Nguyen DQ, Bank AJ, Ormaza S, Bolman RM, III. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg. 2000;69:1146-51.
26. Entwistle JW, III, Bolno PB, Holmes E, Samuels LE. Improved survival with ventricular assist device support in cardiogenic shock after myocardial infarction. Heart Surg Forum. 2003;6:316-9.
27. Samuels LE, Holmes EC, Garwood P, Ferdinand F. Initial experience with the Abiomed AB5000 ventricular assist device system. Ann Thorac Surg. 2005;80:309-12.
28. Anderson M, Acker MA, Kasirajan V, Madani M, Naka Y, Raess D, et al. Mechanical circulatory support improves recovery outcomes in profound cardiogenic shock post acute myocardial infarction: a US multicenter study. Am J Cardiol. 2005;96:Suppl.. 11H.
29. Vogel RA, Shawl F, Tommaso C, O'Neill W, Overlie P, O'Toole J, et al. Initial report of the national registry of elective cardiopulmonary bypass supported coronary angioplasty. J Am Coll Cardiol. 1990;15:23-9.
30. Scholz KH, Dubois-Rande JL, Urban P, Morice MC, Loisance D, Smalling RW, et al. Clinical experience with the percutaneous hemopump during high-risk coronary angioplasty. Am J Cardiol. 1998;82:1107-10, A6.
31. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104:2917-22.
32. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-83.
33. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469-8.
34. Meyns B, Autschbach R, Boning A, Konertz W, Matschke K, Schondube F, et al. Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomized trial. Eur J Cardiothorac Surg. 2002;22:112-7.
35. Sjauw KD, Remmelink M, Lam KY, Baan Jr J, Schaaf RJ, Vis MM, et al. Demonstration of LV unloading on echocardiography during high risk PCI with a left ventricular assist device. Acute Cardiac Care. 2007;9:125-6.
36. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg. 2003;51:312-7.
37. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;77:1642-7.
38. Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A, Olschewski M, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg. 2004;127:812-22.
39. Henriques JP, Remmelink M, Baan J, Jr, van der Schaaf RJ, Vis MM, Koch KT, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97:990-2.
40. Benali K, Henriques JP. Percutaneous circulatory support during high-risk angioplasty procedures: A multicenter experience with Impella technology. J Am Coll Cardiol. 2007;49:Suppl.901-912-1B.'
41. Remmelink M, Sjauw KD, Henriques JP, Vis MM, Koch KT, Tijssen JG, et al. Effects of Left Ventricular Unloading by Impella Recover LP2.5 on Coronary Hemodynamics. Catheter Cardiovasc Interv. 2007; in press.
42. Sjauw KD, Remmelink M, Baan J Jr, Schaaf RJ, Vis MM, Koch KT, et al. Preliminary experience of the MACH 2 trial: Safety and feasibility of left ventricular support with the Impella recover LP 2.5 device in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007;49:Suppl.914-211-29B.
43. Seyfarth M, Fröhlich G, Sibbing D, Bott-Flügel L, Bauer I, Dirschinger J, et al. Left ventricular assist device (Impella LP 2.5) versus intraaortic ballon counterpulsation for patients with cardiogenic shock by myocardial infarction: A prospective, randomized trial (ISAR-SHOCK). Presented at: the late-breaking emerging technologies and innovations session of the 56th Annual Scientific Session of the American College of Cardiology; New Orleans, LA, 23 March 2007.
44. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700-7.
45. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM, et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J. 2006;152:565-72.
46. Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de WF, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297:1657-66.
47. Henriques JP, de Mol BA. New percutaneous mechanical left ventricular support for acute myocardial infarction. The AMC MACH program. Nature Clinical Practice Cardiovascular Medicine. 2007; in press.
48. Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, et al. Clinical experience with the Tandem Heart percutaneous ventricular assist device. Tex Heart Inst J. 2006;33:111-5.